Showing results (51-60 of 62) with videos related to
Sort By:
Pageof 7
Scientific Reports|November 21, 2019
A comprehensive evaluation of pathogenic mutations in primary cutaneous melanomas, including the identification of novel loss-of-function variantsIvana Ticha, Jan Hojny, Romana Michalkova, et al.Molecular Cell|September 1, 2022
The TRESLIN-MTBP complex couples completion of DNA replication with S/G2 transitionGijs Zonderland, Riccardo Vanzo, Sampath Amitash Gadi, et al.Biomedicines|October 14, 2020
Identification of Germline Mutations in Melanoma Patients with Early Onset, Double Primary Tumors, or Family Cancer History by NGS Analysis of 217 GenesLenka Stolarova, Sandra Jelinkova, Radka Storchova, et al.JCO Precision Oncology|September 2, 2025
Case-Control Study for 23 Cancer Types With Functional Analysis of CHEK2: Risk Estimation and Clinical Recommendations in East AsiaYuri Takehara, Yoshiaki Usui, Lenka Stolařová, et al.Cell Death & Disease|October 30, 2019
Truncated PPM1D impairs stem cell response to genotoxic stress and promotes growth of APC-deficient tumors in the mouse colonMonika Burocziova, Kamila Burdova, Andra S Martinikova, et al.Science (New York, N.Y.)|April 28, 2022
Cancer cells use self-inflicted DNA breaks to evade growth limits imposed by genotoxic stressBrian D Larsen, Jan Benada, Philip Yuk Kwong Yung, et al.Nature Communications|December 1, 2025
MCL1 modulates mTORC1 signaling to promote bioenergetics and tumorigenesisWentao Gui, Petr Paral, Bhavuk Dhamija, et al.International Journal of Cancer|May 4, 2019
Identification of deleterious germline CHEK2 mutations and their association with breast and ovarian cancerPetra Kleiblova, Lenka Stolarova, Katerina Krizova, et al.Cancers|April 17, 2020
Multigene Panel Germline Testing of 1333 Czech Patients with Ovarian CancerKlara Lhotova, Lenka Stolarova, Petra Zemankova, et al.JCI Insight|April 22, 2025
G6PC3 promotes genome maintenance and is a candidate mammary tumor suppressorXin Li, Maria Rossing, Ana Moisés da Silva, et al.Pageof 7